Buster Olney cast aspersions on Melky Cabrera, Jose Bautista took offense. Now Olney fires back in his column. After quoting Bautista’s comments about how Melky has done the crime and the time and should be allowed to get on with his life, and after quoting Richard Griffith’s argument that Cabrera is not a poster boy for cheating being worthwhile, Buster says . . .
I’d respectfully disagree . . .Just because somebody doesn’t make as much as Ryan Braun doesn’t mean cheating isn’t worthwhile, and it’s hardly a stretch to suggest that Cabrera made extra cash through his past transgression . . . He signed with the Royals for $1.25 million in 2011 and became a star, at a time when he reportedly became a client of Biogenesis. He was suspended in 2012 while playing for the San Francisco Giants, and the Blue Jays then signed him to a two-year, $16 million deal before anybody knew about Tony Bosch and Biogenesis.
That last little bit is kinda clever: “before anybody knew about Tony Bosch and Biogenesis.” It implies that Melky made his $16 million from the Jays under false pretenses. Which is silly considering the guy was suspended for testing positive for drugs while still with the Giants. My memory is a bit fuzzy about it all, but I seem to recall that a few papers even wrote some stuff about it.
Did Melky get an unfair advantage from cheating? Absolutely. But every cent he’s made from the Blue Jays and every cent he’s making going forward was and will be made with full knowledge of his past transgressions and with the risk of him either cheating again or turning into a pumpkin priced into the deal. If he hadn’t been busted while in San Francisco he would have stood to make way, way more than that. Indeed, conservative estimates before his suspension were that he’d get $50 million over four years, maybe more. Rather than get a windfall as a result of his cheating, Melky took a pretty big hit, financially speaking.
I realize it drives some people crazy that baseball is cool with punishing guys for taking PEDs, letting them back in the game and allowing them to make a living as if they weren’t murderers or something, but that is how it works. Ask the Cardinals and Jhonny Peralta. Ask the Orioles and Nelson Cruz. Ask any number of other players who have taken drugs, gotten suspended and have come back. And it’s how it should work. Punish a guy sharply when he crosses the line. Test players constantly to deter them from cheating. But when a guy has done the time, let him be unless or until he cheats again.
If you don’t like that — and Buster here clearly does not — advocate for lifetime bans on the first offense or get the hell off your high horse.
CC Sabatha made headlines in October when he abruptly left the Yankees to go into alcohol rehab. After a month there he came back and gave interviews about his decision and his battle with the bottle and then disappeared into the offseason the way most players do.
He emerged the other day and spoke with the New York Daily News’ Mark Feinsand and says that he’s ready for baseball once again. Indeed, in some ways he’s more ready now than he usually is by mid February. He’s been throwing bullpen sessions for the past three weeks — he normally waits until he gets to Tamps — and he says his troublesome knee is feeling good.
Sabathia will turn 36 during the season. In 2015 he was 6-10 with a 4.73 ERA in 29 starts and posted his lowest strikeout rate in a decade. Late in the season, however, with the help of a knee brace, he was at his most effective in some time. He won’t need to return to 2008 form in order to help the Yankees this season, but he will need to look more like he did in September if he is to help the Yankees to the playoffs.
The Mets are currently enjoying the spoils of the best young rotation in the game, but the big question is whether this is just a brief window or the start of sustained success. Given the huge prices on the free agent market, it’s going to be next to impossible to keep the band together, but at least one member of the rotation is open to sticking around for the long-term.
While there haven’t been any talks yet, All-Star right-hander Jacob deGrom told Kevin Kernan of the New York Post that he could see himself discussing an extension with the Mets.
“I’m a little bit older, so I might be more willing to do something like that,’’ deGrom told The Post at Mets pre-camp. “You just have to look at what is fair so both sides get a decent deal. It’s something I’d have to look into and make sure I agree with it.’’
It makes sense from deGrom’s perspective. He broke into the majors later than most prospects, so he’ll be 28 this June. Depending on whether he qualifies as a Super Two, he’ll be arbitration-eligible for the first time after either 2016 or 2017. Either way, he’s under team control through 2020, which means that he’s currently on track to hit free agency after his age-32 season. The market might not be kind to him even if he manages to stay healthy, so it could behoove him to get as much guaranteed money as possible right now. The Mets could always decide to play things year-to-year, but perhaps deGrom would be willing to settle for a discount in order to get them to buy out a free agent year or two. It’s a really interesting situation to think about, but odds are the two sides will wait on contract talks until he’s arbitration-eligible for the first time.
DeGrom owns a 2.61 ERA in 52 starts over his first two seasons in the majors. Among starters, only Zack Greinke, Jake Arrieta, and Clayton Kershaw have a lower ERA since the start of 2014.
The Royals and third baseman Mike Moustakas have avoided arbitration by agreeing to a two-year, $14.3 million deal, reports Jon Heyman of MLB Network.
The deal, which was initially discussed last month, buys out Moustakas’ final two years of arbitration. Jeffrey Flanagan of MLB.com reports that it’s believed he’ll make $5.6 million in 2016 and $8.7 million in 2017.
The 27-year-old Moustakas posted an underwhelming .668 OPS over his first four seasons in the majors, but he enjoyed a big postseason in 2014 before breaking out last season by batting .284/.348/.470 with 22 home runs and 82 RBI.
ESPN’s Jerry Crasnick reported this morning that free agent reliever Tommy Hunter required core muscle repair surgery earlier this offseason. Coming off a disappointing 2015, it’s understandable why he’s still on the market, but it sounds like he has at least one significant lead.
Marc Topkin of the Tampa Bay Times hears that the Rays are having “advanced talks” with Hunter as they attempt to add an experienced arm to their bullpen. Nothing is considered close and Hunter is also talking to other clubs. Meanwhile, the Rays have been in touch with veteran reliever Ryan Webb while monitoring the trade market.
Hunter posted a 2.88 ERA as a late-inning arm from 2013-2014, but he compiled a mediocre 4.18 ERA over 58 appearances last season between the Orioles and Cubs. On the bright side, his velocity has held steady and his control is still very good. Despite the down year and core muscle surgery, Topkin writes that Hunter may be holding out for a multi-year deal.